ストックスクリーナーアプリを入手
30.03
37.75%
8.23
アフターアワーズ：
29.00
-1.03
-3.43%
前日終値:
$21.80
開ける：
$21.89
24時間の取引高:
1.49M
Relative Volume:
1.40
時価総額：
$48.05M
収益：
-
当期純損益:
$-38.35M
株価収益率:
-20.71
EPS:
-1.45
ネットキャッシュフロー:
$-36.91M
1週間 パフォーマンス:
+32.70%
1か月 パフォーマンス:
+37.63%
6か月 パフォーマンス:
+815.02%
1年 パフォーマンス:
+551.41%
1日の値動き範囲:
$21.89
$30.03
1週間の範囲:
$19.85
$30.03
52週間の値動き範囲:
$2.01
$38.33
Galecto Inc Stock (GLTO) Company Profile
Compare GLTO vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
30.03 | 34.88M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 開始されました | Leerink Partners | Outperform |
| 2025-12-01 | 開始されました | Guggenheim | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-11-23 | 開始されました | BofA Securities | Buy |
| 2020-11-23 | 開始されました | Credit Suisse | Outperform |
| 2020-11-23 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Galecto Inc (GLTO) 最新ニュース
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Dividend Watch: Can Galecto Inc lead its sector in growthEarnings Miss & High Conviction Buy Zone Picks - baoquankhu1.vn
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million - bitget.com
Galecto prices $275 million public offering at $19 per share By Investing.com - Investing.com Nigeria
Galecto Prices Upsized Public Offering to Fund DMR-001 - TipRanks
Galecto Signs Underwriting Agreement With Jefferies and Leerink Partners - TradingView
Galecto shares fall after $275 million equity raise at discount By Investing.com - Investing.com South Africa
GLTO: Key Managers Involved in Recent Offering - GuruFocus
Galecto to raise USD 275m in share issue - medwatch.com
Galecto Prices $275 Mln Public Offering At $19 Per Share, Stock Down - Nasdaq
Cancer drug developer Galecto raises $275M in stock sale - Stock Titan
Hans Schambye resigns from Galecto – takes top position at Boost Pharma - medwatch.com
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock - 富途牛牛
Galecto Prices $275 Million Offering - marketscreener.com
Galecto Announces Pricing of $275 Million Underwritten Public Offering - The Manila Times
Galecto, Inc. Announces Pricing of $275 Million Underwritten Public Offering of Common Stock - Quiver Quantitative
Galecto announces pricing of $275 million underwritten public offering - marketscreener.com
Galecto Announces Pricing of $275 Million Underwritten Public Offering - GlobeNewswire Inc.
Galecto announces public offering of common stock and preferred shares By Investing.com - Investing.com Nigeria
Hans Schambye on Galecto exit: It happened by mutual agreement - medwatch.com
Galecto stock falls after announcing public offering of common stock By Investing.com - Investing.com India
Galecto stock falls after announcing public offering of common stock - Investing.com
Galecto (GLTO) Files Automatic Mixed Securities Shelf - GuruFocus
Cancer drug developer Galecto plans stock sale to fund antibody trials - Stock Titan
Galecto CEO Transition and Major Shareholder-Approved Restructuring - TipRanks
Galecto announces CEO transition, share authorization increase, and shareholder approvals - Investing.com India
Galecto (NASDAQ: GLTO) CEO departs amid big share increase and Cayman move - Stock Titan
Returns Recap: How sensitive is Galecto Inc to inflation2025 Market Outlook & High Yield Equity Trading Tips - baoquankhu1.vn
Galecto (NASDAQ:GLTO) Raised to Strong-Buy at Lifesci Capital - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail
Growth Report: Will Galecto Inc announce a stock splitJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - baoquankhu1.vn
How sensitive is Galecto Inc to inflationTrade Performance Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Galecto Showcases New mutCALR MPN Pipeline at JPM - TipRanks
Risk Report: Is dMY Squared Technology Group Inc Equity Warrant likely to announce a buybackJuly 2025 Update & Entry Point Confirmation Signals - baoquankhu1.vn
Is Galecto Inc a stock for growth or value investorsJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
Fund Flows: Should I set a stop loss on CNFR2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
Exit Recap: What is Dow Incs book value per sharePortfolio Value Summary & Technical Buy Zone Confirmations - baoquankhu1.vn
Is Galecto Inc. stock supported by innovation pipelineTechnical Breakout Signals & Maximize Gains Professionally - Bollywood Helpline
Galecto, Inc. (NASDAQ:GLTO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Movement Recap: Is Galecto Incs ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - baoquankhu1.vn
Galecto (GLTO) Price Target Increased by 13.89% to 41.82 - Nasdaq
Investment Recap: Can Galecto Inc stock double in next 5 yearsEarnings Recap Report & Safe Entry Point Alerts - Bộ Nội Vụ
Galecto on track to submit IND for mutCALR antibody by mid-2026 - Investing.com Nigeria
Galecto on track to submit IND for mutCALR antibody by mid-2026 By Investing.com - Investing.com India
Galecto (GLTO) Sets Ambitious Clinical Milestones for 2026 - GuruFocus
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones - The Manila Times
Galecto, Inc. Reports Strategic Shift and Financial Results - MSN
Galecto Completes Acquisition of Damora Therapeutics - MSN
Galecto (NASDAQ:GLTO) Upgraded at Leerink Partnrs - Defense World
What risks investors should watch in Galecto Inc. stock2025 Year in Review & Consistent Growth Equity Picks - ulpravda.ru
Is Galecto Inc. stock attractive for hedge fundsJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Galecto Inc (GLTO) 財務データ
収益
当期純利益
現金流量
EPS
Galecto Inc (GLTO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director |
Feb 09 '26 |
Option Exercise |
0.00 |
8,713,000 |
0 |
5,809,000 |
| Schambye Hans T. | Chief Executive Officer |
Jan 02 '26 |
Sale |
21.38 |
700 |
14,966 |
4,682 |
| Winslow Garrett | General Counsel |
Jan 02 '26 |
Sale |
21.38 |
255 |
5,452 |
1,854 |
| Firmani Lori | Chief Financial Officer |
Jan 02 '26 |
Sale |
21.41 |
135 |
2,890 |
931 |
| Schambye Hans T. | Chief Executive Officer |
Jul 03 '25 |
Sale |
3.38 |
735 |
2,484 |
4,022 |
| Winslow Garrett | General Counsel |
Jul 03 '25 |
Sale |
3.39 |
260 |
881 |
1,429 |
| Firmani Lori | Interim CFO |
Jul 03 '25 |
Sale |
3.39 |
147 |
498 |
692 |
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):